GRASSI, ILARIA
GRASSI, ILARIA
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors
2023 Bocchini, Martine; Tazzari, Marcella; Ravaioli, Sara; Piccinini, Filippo; Foca, Flavia; Tebaldi, Michela; Nicolini, Fabio; Grassi, Ilaria; Severi, Stefano; Calogero, Raffaele Adolfo; Arigoni, Maddalena; Schrader, Joerg; Mazza, Massimiliano; Paganelli, Giovanni
Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis.
2017 Lopci, E; Grizzi, F; Russo, C; Toschi, L; Grassi, I; Cicoria, G; Lodi, F; Mattioli, S; Fanti, S.
Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT.
2016 Lopci, E; Grassi, I; Rubello, D; Colletti, Pm; Cambioli, S; Gamboni, A; Salvi, F; Cicoria, G; Lodi, F; Dazzi, C; Mattioli, S; Fanti, S.
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence
2014 Lopci, E; Grassi, I; Chiti, A; Nanni, C; Cicoria, G; Toschi, L; Fonti, C; Lodi, F; Mattioli, S; Fanti, S.
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome.
2009 Gambineri A.; Repaci A.; Patton L.; Grassi I.; Pocognoli P.; Cognigni GE.; Pasqui F.; Pagotto U.; Pasquali R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors | Bocchini, Martine; Tazzari, Marcella; Ravaioli, Sara; Piccinini, Filippo; Foca, Flavia; Tebaldi, ...Michela; Nicolini, Fabio; Grassi, Ilaria; Severi, Stefano; Calogero, Raffaele Adolfo; Arigoni, Maddalena; Schrader, Joerg; Mazza, Massimiliano; Paganelli, Giovanni | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | 0073_2023_FrontiersInOnc_Bocchini.pdf; 1136331.zip |
| Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis. | Lopci, E; Grizzi, F; Russo, C; Toschi, L; Grassi, I; Cicoria, G; Lodi, F; Mattioli, S; Fanti, S. | 2017-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT. | Lopci, E; Grassi, I; Rubello, D; Colletti, Pm; Cambioli, S; Gamboni, A; Salvi, F; Cicoria, G; Lod...i, F; Dazzi, C; Mattioli, S; Fanti, S. | 2016-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence | Lopci, E; Grassi, I; Chiti, A; Nanni, C; Cicoria, G; Toschi, L; Fonti, C; Lodi, F; Mattioli, S; F...anti, S. | 2014-01-01 | AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. | Gambineri A.; Repaci A.; Patton L.; Grassi I.; Pocognoli P.; Cognigni GE.; Pasqui F.; Pagotto U.;... Pasquali R. | 2009-01-01 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | - | 1.01 Articolo in rivista | - |